The 🆕 2026 AHA/ACC/ADA/ASN Guideline
for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes), chronic kidney disease (CKD) and cardiovascular disease.
" The document retires, replaces and expands upon the 2013 Guideline for the Management of Overweight and Obesity in Adults.
Read the full guideline in #JACC 👉 https://bit.ly/4vvaJ7C #ClinicalGuidelines #cvMetabolic #CVD